Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-02-25 @ 8:26 PM
Study NCT ID:
NCT02556333
Status:
TERMINATED
Last Update Posted:
2017-11-14
First Post:
2015-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Emtricitabine/Tenofovir Alafenamide as Salvage ART
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-16
Start Date Type:
None
Primary Completion Date:
2016-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-18
First Submit QC Date:
None
Study First Post Date:
2015-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-15
Results First Submit QC Date:
None
Results First Post Date:
2017-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-17
Last Update Post Date:
2017-11-14
Last Update Post Date Type:
ACTUAL